Skip to main content
JPMorganInvestment

GT Metabolic Solutions Raises Series C Led By J.P. Morgan Life Sciences Private Capital

Source: Autobound Signal API · 61 signals tracked for JPMorgan · updated

Get JPMorgan's live signals in Claude or ChatGPT, or by API

AskWhat changed at JPMorgan this week? Use Autobound signals for jpmorgan.com.

What happened

J.P. Morgan Life Sciences Private Capital led a Series C growth investment in GT Metabolic Solutions.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

GT Metabolic Solutions has secured a Series C growth investment from J.P. Morgan Life Sciences Private Capital to accelerate commercialization of its magnetic anastomosis technology. The financing will support the company's global commercial launch and expansion into additional surgical and therapeutic applications, including endoscopic and colorectal procedures. GT Metabolic develops a linear magnetic anastomosis system that creates gastrointestinal connections without incisions, sutures, or staples. The technology uses magnetic compression to create anastomoses while avoiding permanent foreign material that could interfere with healing. The system can be used with endoscopic, robotic, or laparoscopic surgical approaches. GT Metabolic said gastrointestinal anastomotic procedures can result in serious complications such as leaks and bleeding, which can lead to sepsis, hospital readmission, and death. The company's magnetic platform is designed to create seamless connections while preserving natural biology and potentially reducing complication rates. GT Metabolic was the first company to receive both an FDA De Novo grant and 510(k) clearance for magnetic technology used to create compression anastomoses. The J.P. Morgan financing represents the company's first institutional financing partnership. GT Metabolic plans to use the proceeds for product development, surgeon...

Keep reading with a free account

The rest of this article, and every signal for JPMorgan, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Investment

What this signalsAn investment often shows where the company plans to grow.

Round
Series C
Financing type
Equity

Companies

  • GT Metabolic SolutionsRelated companygtmetabolic.com

More investment signals at other companies

The full record

From the Signal API record

Extraction

Confidence
95%
Detected
Oct 29, 2026
signal_type
news
signal_subtype
invests_into

Use this data

Get every investment signal for JPMorgan and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at JPMorgan this week?”

  2. Send it to your own tools

    The Signal API returns investment signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/2b76b101-018f-0be6-a2d2-56314f3a92c2 returns this record as JSON. POST /v1/companies/enrich returns every signal for jpmorgan.com.

{
  "signal_id": "2b76b101-018f-0be6-a2d2-56314f3a92c2",
  "signal_type": "news",
  "signal_subtype": "invests_into",
  "detected_at": "2026-10-29T21:23:39+00:00",
  "company": {
    "name": "JPMorgan",
    "domain": "jpmorgan.com"
  },
  "data": {
    "url": "https://pulse2.com/gt-metabolic-solutions-raises-series-c-led-by-j-p-morgan-life-sciences-private-capital/",
    "title": "GT Metabolic Solutions Raises Series C Led By J.P. Morgan Life Sciences Private Capital - Pulse 2.0",
    "excerpt": "GT Metabolic Solutions has secured a Series C growth investment from J.P. Morgan Life Sciences Private Capital to accelerate commercialization of its magnetic anastomosis technology. The financing will support the company’s global commercial launch and expansion into additional surgical and therapeutic applications, including endoscopic and colorectal procedures. GT Metabolic develops a linear magnetic anastomosis system that creates gastrointestinal connections without incisions, sutures, or staples. The technology uses magnetic compression to create anastomoses while avoiding permanent foreign material that could interfere with healing. The system can be used with endoscopic, robotic, or laparoscopic surgical approaches. GT Metabolic said gastrointestinal anastomotic procedures can result in serious complications such as leaks and bleeding, which can lead to sepsis, hospital readmission, and death. The company’s magnetic platform is designed to create seamless connections while preserving natural biology and potentially reducing complication rates. GT Metabolic was the first company to receive both an FDA De Novo grant and 510(k) clearance for magnetic technology used to create compression anastomoses. The J.P. Morgan financing represents the company’s first institutional financing partnership. GT Metabolic plans to use the proceeds for product development, surgeon training...",
    "summary": "J.P. Morgan Life Sciences Private Capital led a Series C growth investment in GT Metabolic Solutions.",
    "planning": false,
    "image_url": "https://cdn.pulse2.com/cdn/2026/10/GT-Metabolic-Solutions-Logo.jpeg",
    "confidence": 0.95,
    "published_at": "2026-10-29T21:23:39Z",
    "article_sentence": "GT Metabolic Solutions has secured a Series C growth investment from J.P. Morgan Life Sciences Private Capital to accelerate commercialization of its magnetic anastomosis technology.",
    "financing_type_tags": [
      "equity"
    ],
    "related_company_name": "GT Metabolic Solutions",
    "related_company_domain": "gtmetabolic.com",
    "financing_type_normalized": "series_c"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.